PreprintCited by 2Regulation of Appetite and ObesityPharmacology and Obesity TreatmentEnzyme Structure and Function

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

A small molecule PTER-selective inhibitor reduces food intake and body weight

Open access

Preprint — published as 10.1016/j.chembiol.2026.02.005 · Paper page

Abstract

Summary: PTER (phosphotriesterase-related) is an amidohydrolase that mediates catabolism of the anorexigenic taurine metabolite N-acetyltaurine. However, the structural basis of PTER ligand binding and catalysis remain unknown, limiting our ability to harness this pathway therapeutically. Here we solve crystal structures of a eukaryotic PTER in apo and product-bound forms. These structures uncover an unexpected pocket homology between PTER and histone deacetylase (HDAC) enzymes. We exploit this similarity to engineer a first-in-class substrate-competitive PTER inhibitor called PTERi with nanomolar potency and >100-fold selectivity for PTER over HDACs in vitro. Administration of PTERi to diet-induced obese mice reduces feeding, enhances GLP1-RA (glucagon like peptide 1 receptor agonist)-induced weight loss, and prevents weight regain after GLP1-RA discontinuation. The structure of PTER connects histone and metabolite deacetylation into a parallel conceptual framework and enables proof-of-concept data for pharmacological inhibition of PTER in obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.64898/2026.01.26.701829

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Corso, G. , Stärk, H. , Jing, B. , Barzilay, R. & Jaakkola, T. Diffdock: Diffusion Steps, Twists, and Turns for Molecular Docking. 11th International Conference on Learning Representations, ICLR 2023 1–33 (2023).

Cited by

Sorted by citations

Metadata

Authors
Fu, S., Wang, L., Li, V. L., Lyu, X., Wei, W., Shi, X., Deng, S., Barber, J. L., Tahir, U. A., Adams, C., Carson, A., Hidalgo, B., Raffield, L. M., Wilson, J. G., Razumkov, H., Xiao, S., Spaas, J., Fernandez, D., Zhang, T., Gerszten, R. E., Benson, M. D., Gray, N. S., Hinshaw, S. M., & Long, J. Z.
Affiliations
  • Stanford Medicine (US)
  • Stanford University (US)
  • Beth Israel Deaconess Medical Center (US)
  • University of Alabama at Birmingham (US)
  • University of North Carolina at Chapel Hill (US)
  • Sarafan ChEM-H, Stanford University, Stanford, CA, USA
Corresponding author
Long, Jonathan Z.
Venue
Cell chemical biology
Publisher
openRxiv
Published
2026-01-28
Volume
33
Issue
3
Pages
353-363.e7
ISSN
2451-9448 (ISSN-L)
OpenAlex
W7134286800
Cited by
2
References
44
Citations by year
2026: 2
FWCI
6.45
Type
journal article
Language
en
Open access
Locations
  • Cell chemical biology (publishedVersion)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (submittedVersion, cc-by-nc)
  • PubMed Central (submittedVersion)
Funders
  • Ono Pharma Foundation
  • National Institutes of Health (1r01dk137983-01a1)
  • Wu Tsai Neurosciences Institute, Stanford University
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124265, R01DK136526)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords
amidohydrolase, small molecule inhibitors, substrate-competitive inhibition, crystal structure, obesity, dietary intake, body weight, GLP-1 receptor agonists, weight regain, diet-induced obesity, enzyme selectivity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review